Literature DB >> 21345759

Clinical report: a patient with primary peritoneal mesothelioma that has improved after taking citric acid orally.

A H Bucay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21345759     DOI： 10.1016/j.clinre.2010.12.011

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN： 2210-7401            Impact factor:   2.947


× No keyword cloud information.
  10 in total

1.  Citrate kills tumor cells through activation of apical caspases.

Authors:  Björn Kruspig; Azadeh Nilchian; Sten Orrenius; Boris Zhivotovsky; Vladimir Gogvadze
Journal:  Cell Mol Life Sci       Date:  2012-10-10       Impact factor: 9.261

2.  Metabolomics in bladder cancer: a systematic review.

Authors:  Yidong Cheng; Xiao Yang; Xiaheng Deng; Xiaolei Zhang; Pengchao Li; Jun Tao; Chao Qin; Jifu Wei; Qiang Lu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 3.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

Review 4.  Tumor microenvironment metabolites directing T cell differentiation and function.

Authors:  Xia Liu; Daniel F Hoft; Guangyong Peng
Journal:  Trends Immunol       Date:  2021-12-29       Impact factor: 16.687

5.  Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay.

Authors:  Raphael Cândido Apolinário Peixoto; Ana Luisa Miranda-Vilela; José de Souza Filho; Marcella Lemos' Brettas Carneiro; Ricardo G S Oliveira; Matheus Oliveira da Silva; Aparecido R de Souza; Sônia Nair Báo
Journal:  Tumour Biol       Date:  2014-12-21

6.  Effect of Food Additive Citric Acid on The Growth of Human Esophageal Carcinoma Cell Line EC109.

Authors:  Xiaoguang Chen; Qiongxia Lv; Yumei Liu; Wen Deng
Journal:  Cell J       Date:  2016-09-26       Impact factor: 2.479

7.  Human serum metabolomic analysis reveals progression for high blood pressure in type 2 diabetes mellitus.

Authors:  Yin Zhang; Heru Zhao; Bin Liu; Haiyang Shu; Lulu Zhang; Mei Bao; Wenjun Yi; Yong Tan; Xinyu Ji; Chi Zhang; Ning Zhao; Guoming Pang; Dan He; Yuexi Wang; Li Li; Jianfeng Yi; Cheng Lu
Journal:  BMJ Open Diabetes Res Care       Date:  2021-10

8.  Citrate Promotes Excessive Lipid Biosynthesis and Senescence in Tumor Cells for Tumor Therapy.

Authors:  Yangjing Zhao; Xia Liu; Fusheng Si; Lan Huang; Aiqin Gao; Wenli Lin; Daniel F Hoft; Qixiang Shao; Guangyong Peng
Journal:  Adv Sci (Weinh)       Date:  2021-11-07       Impact factor: 16.806

9.  Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia.

Authors:  Seon Yoo Kim; Dongwoo Kim; Jisu Kim; Hae Young Ko; Won Jin Kim; Youngjoo Park; Hye Won Lee; Dai Hoon Han; Kyung Sik Kim; Sunghyouk Park; Misu Lee; Mijin Yun
Journal:  Cancers (Basel)       Date:  2022-07-10       Impact factor: 6.575

10.  Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway.

Authors:  Jian-Guo Ren; Pankaj Seth; Huihui Ye; Kun Guo; Jun-Ichi Hanai; Zaheed Husain; Vikas P Sukhatme
Journal:  Sci Rep       Date:  2017-07-03       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.